Pharmaceutical Hot Melt Extrusion Equipment Strategic Research Report 2025-2030, Featuring Baker Perkins, Coperion, Leistritz, Milacron, Thermo Fisher Scientific, Xtrutech – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Hot Melt Extrusion Equipment – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Pharmaceutical Hot Melt Extrusion Equipment was valued at US$34.7 Million in 2024 and is projected to reach US$44.8 Million by 2030, growing at a CAGR of 4.3% from 2024 to 2030. This … [Read more…]

75 Per Cent of People in Eastern/Northern Ontario Want Provincial Government to Prioritize Spending on Public Hospitals Instead of Private Clinics: New Poll

OCHU-CUPE media conference in Ottawa at 10am on Tuesday to release full findings of new Nanos poll on privatization OTTAWA, Ontario–(BUSINESS WIRE)–Just over 10 days after the recent Ontario budget allocated $280 million for expansion of surgeries and diagnostic tests in private clinics while restraining hospital funding, a new poll shows that 75 per cent … [Read more…]

Merck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults With Hyperlipidemia

Enlicitide demonstrated statistically significant and clinically meaningful reductions in LDL-C in both Phase 3 CORALreef HeFH and CORALreef AddOn trials Enlicitide, a novel macrocyclic peptide, has the potential to be the first approved oral PCSK9 inhibitor RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive … [Read more…]

Azafaros to Present at BIO International Convention 2025 Following Successful €132M Series B Financing

LEIDEN, Netherlands–(BUSINESS WIRE)–#Adults–Azafaros, a clinical-stage biotechnology company developing novel therapies for rare lysosomal storage disorders (LSDs), today announced that it will present at the 2025 BIO International Convention taking place in Boston, USA, from 16-19 June. The company’s presentation is scheduled for Monday, June 16 at 16:45 ET in Room 153B. The presentation will highlight … [Read more…]

Samsung Bioepis Enters into a Strategic Partnership with NIPRO for Commercialization of Multiple Biosimilars in Japan

Samsung Bioepis expands its presence in Japanese market through partnership with NIPRO Corporation Marks a step forward in widening treatments options across multiple therapeutic areas including immunology for patients in Japan INCHEON, Korea–(BUSINESS WIRE)–#InnovatingAccess–Samsung Bioepis Co., Ltd. (“Samsung Bioepis”) announced today that the company has entered into a license, development and commercialization agreement with NIPRO … [Read more…]

Party With a Purpose: Republic Bank hosts fifth annual Juneteenth Event to improve health outcomes in West Louisville

Since 2020, Republic and community partners have offered free life-saving screenings and educational resources to celebration attendees LOUISVILLE, Ky.–(BUSINESS WIRE)–Today, Republic Bank & Trust Company (“Republic” or “the Bank”) hosted the fifth annual Juneteenth Event at the Republic Bank Foundation YMCA. Republic partnered with Kentucky African Americans Against Cancer (KAAAC) and other community organizations to … [Read more…]

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK–(BUSINESS WIRE)–Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 39,345 shares of the Company’s common stock … [Read more…]

JCR Pharmaceuticals Marks 50 Years of Innovation with Launch of One-of-a-Kind Global Website

– A refreshed global brand signals JCR’s expanded international presence and unwavering focus on rare and genetic diseases worldwide – HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the launch of its new global website. As the company … [Read more…]

UAE $135+ Mn Insulin Pumps Markets Competition, Forecast & Opportunities, 2030F: How Digital Integration is Revolutionizing Insulin Pumps Market in the UAE’s Expanding Diabetes Care System – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “UAE Insulin Pumps Market, By Region, Competition, Forecast & Opportunities, 2020-2030F” has been added to ResearchAndMarkets.com’s offering. The UAE Insulin Pumps Market was valued at USD 64.35 Million in 2024 and is expected to reach USD 135.34 Million by 2030, rising at a CAGR of 13.15%. This market is gaining prominence as part … [Read more…]

Aethera Biotech Forges Strategic Collaboration with China’s Shang Renée Skincare to Introduce CROP (Controlled Release of Optimized Plants) Patent Technology into Chinese Market

ROME–(BUSINESS WIRE)–Aethera Biotech officially announced a strategic partnership with Chinese premium skincare brand Shang Renée, marking the latter as Aethera Biotech’s first collaborative partner in the Chinese market. This collaboration not only introduces the internationally pioneering CROP patent technology to China but has also led to the joint establishment of the CELL Laboratory in Italy, … [Read more…]